DK3083562T3 - Cykliske phenoxyethylaminderivater og deres aktivitet som EP4-receptormodulatorer - Google Patents
Cykliske phenoxyethylaminderivater og deres aktivitet som EP4-receptormodulatorerInfo
- Publication number
- DK3083562T3 DK3083562T3 DK14827907.8T DK14827907T DK3083562T3 DK 3083562 T3 DK3083562 T3 DK 3083562T3 DK 14827907 T DK14827907 T DK 14827907T DK 3083562 T3 DK3083562 T3 DK 3083562T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclic
- activity
- receptor modulators
- phenoxyethylamine derivatives
- phenoxyethylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361916827P | 2013-12-17 | 2013-12-17 | |
| PCT/US2014/069743 WO2015094902A1 (en) | 2013-12-17 | 2014-12-11 | Phenoxyethyl cyclic amine derivatives and their activity as ep4 receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3083562T3 true DK3083562T3 (da) | 2017-11-13 |
Family
ID=52355185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14827907.8T DK3083562T3 (da) | 2013-12-17 | 2014-12-11 | Cykliske phenoxyethylaminderivater og deres aktivitet som EP4-receptormodulatorer |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9776964B2 (da) |
| EP (1) | EP3083562B1 (da) |
| JP (1) | JP6212644B2 (da) |
| KR (1) | KR101807981B1 (da) |
| CN (1) | CN105793242B (da) |
| AU (1) | AU2014366361B2 (da) |
| BR (1) | BR112016011016A8 (da) |
| CA (1) | CA2928593A1 (da) |
| CY (1) | CY1119583T1 (da) |
| DK (1) | DK3083562T3 (da) |
| EA (1) | EA028921B1 (da) |
| ES (1) | ES2651858T3 (da) |
| HR (1) | HRP20171850T1 (da) |
| HU (1) | HUE035698T2 (da) |
| LT (1) | LT3083562T (da) |
| ME (1) | ME02896B (da) |
| MX (1) | MX2016007566A (da) |
| NO (1) | NO3221486T3 (da) |
| PL (1) | PL3083562T3 (da) |
| PT (1) | PT3083562T (da) |
| RS (1) | RS56615B1 (da) |
| SI (1) | SI3083562T1 (da) |
| WO (1) | WO2015094902A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20180323A (es) | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
| CA3063788A1 (en) | 2017-05-18 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives |
| LT3625228T (lt) | 2017-05-18 | 2021-10-25 | Idorsia Pharmaceuticals Ltd | Pirimidino dariniai, kaip pge2 receptoriaus moduliatoriai |
| HUE056080T2 (hu) | 2017-05-18 | 2022-01-28 | Idorsia Pharmaceuticals Ltd | Fenilszármazékok mint PGE2 receptor modulátorok |
| AR111807A1 (es) | 2017-05-18 | 2019-08-21 | Idorsia Pharmaceuticals Ltd | Derivados de benzofurano y benzotiofeno como moduladores del receptor pge2 |
| EA039630B1 (ru) | 2017-05-18 | 2022-02-18 | Идорсия Фармасьютиклз Лтд | N-замещенные индольные производные |
| CN109970625B (zh) * | 2017-12-28 | 2021-02-26 | 新发药业有限公司 | 一种5r-苄氧氨基哌啶-2s-甲酸或其衍生物的制备方法 |
| JP2022536607A (ja) * | 2019-06-11 | 2022-08-18 | テオン セラピューティクス，インク． | プロスタグランジンｅ２受容体４アンタゴニスト及びその使用 |
| EP3885339A1 (en) | 2020-03-27 | 2021-09-29 | Rottapharm Biotech S.r.l. | Process for the preparation of (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic acid or a salt thereof |
| JPWO2022102731A1 (da) | 2020-11-13 | 2022-05-19 | ||
| CN112608271A (zh) * | 2020-11-26 | 2021-04-06 | 安润医药科技（苏州）有限公司 | 酰胺衍生物及其在制备ep4受体拮抗剂中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2500157C2 (de) | 1975-01-03 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung |
| DE60307607T2 (de) | 2002-03-18 | 2007-08-09 | Pfizer Products Inc., Groton | Verwendung von selektiven ep4 rezeptor agonisten zur behandlung von krankheiten |
| PL1660492T3 (pl) * | 2003-07-28 | 2009-01-30 | Janssen Pharmaceutica Nv | Pochodne benzoimidazolu, benzotiazolu i benzoksazolu oraz ich zastosowanie jako modulatorów LTA4H |
| AU2004268839A1 (en) * | 2003-09-03 | 2005-03-10 | Pfizer Inc. | Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists |
| WO2005105733A1 (en) | 2004-05-04 | 2005-11-10 | Pfizer Japan Inc. | Ortho substituted aryl or heteroaryl amide compounds |
| MXPA06011555A (es) | 2004-05-04 | 2006-12-15 | Pfizer | Compuestos de metil-aril o heteroaril-amida sustituida. |
| ES2392192T3 (es) | 2006-04-24 | 2012-12-05 | Merck Canada Inc. | Derivados de indol amida como antagonistas del receptor EP4 |
| WO2007143825A1 (en) | 2006-06-12 | 2007-12-21 | Merck Frosst Canada Ltd. | Indoline amide derivatives as ep4 receptor ligands |
| JP5408434B2 (ja) * | 2007-07-03 | 2014-02-05 | アステラス製薬株式会社 | アミド化合物 |
| BRPI0912778B1 (pt) * | 2008-05-14 | 2019-04-30 | Astellas Pharma Inc. | Composto de amida, composição farmacêutica compreendedo dito composto e uso do mesmo para o tratamento de insuficiência renal crônica ou nefropatia diabética |
| WO2010019796A1 (en) | 2008-08-14 | 2010-02-18 | Chemietek, Llc | Heterocyclic amide derivatives as ep4 receptor antagonists |
| JP6152643B2 (ja) | 2010-02-22 | 2017-06-28 | 株式会社ＡｓｋＡｔ | Ｉｌ−２３媒介疾患を治療するためのｅｐ４受容体拮抗薬の使用 |
| US9120824B2 (en) | 2011-07-04 | 2015-09-01 | Rottapharm Biotech S.R.L. | Cyclic amine derivatives as EP4 receptor agonists |
| JP5813223B2 (ja) * | 2011-07-04 | 2015-11-17 | ロッタファーム バイオテック エス アール エル | Ｅｐ４レセプターアンタゴニストとしての環状アミン誘導体 |
| AR091429A1 (es) * | 2012-06-29 | 2015-02-04 | Lilly Co Eli | Compuestos de fenoxietil piperidina |
| TW201443004A (zh) | 2013-02-15 | 2014-11-16 | Lilly Co Eli | 苯氧基乙氧基化合物 |
| TWI636046B (zh) * | 2013-05-17 | 2018-09-21 | 美國禮來大藥廠 | 苯氧基乙基二氫－１ｈ－異喹啉化合物 |
-
2014
- 2014-12-11 AU AU2014366361A patent/AU2014366361B2/en not_active Ceased
- 2014-12-11 EP EP14827907.8A patent/EP3083562B1/en active Active
- 2014-12-11 CA CA2928593A patent/CA2928593A1/en not_active Abandoned
- 2014-12-11 ES ES14827907.8T patent/ES2651858T3/es active Active
- 2014-12-11 SI SI201430434T patent/SI3083562T1/sl unknown
- 2014-12-11 PL PL14827907T patent/PL3083562T3/pl unknown
- 2014-12-11 HU HUE14827907A patent/HUE035698T2/en unknown
- 2014-12-11 KR KR1020167015741A patent/KR101807981B1/ko active IP Right Grant
- 2014-12-11 RS RS20171227A patent/RS56615B1/sr unknown
- 2014-12-11 US US15/030,888 patent/US9776964B2/en not_active Expired - Fee Related
- 2014-12-11 BR BR112016011016A patent/BR112016011016A8/pt not_active IP Right Cessation
- 2014-12-11 LT LTEP14827907.8T patent/LT3083562T/lt unknown
- 2014-12-11 DK DK14827907.8T patent/DK3083562T3/da active
- 2014-12-11 WO PCT/US2014/069743 patent/WO2015094902A1/en active Application Filing
- 2014-12-11 JP JP2016538744A patent/JP6212644B2/ja not_active Expired - Fee Related
- 2014-12-11 CN CN201480068170.1A patent/CN105793242B/zh not_active Expired - Fee Related
- 2014-12-11 PT PT148279078T patent/PT3083562T/pt unknown
- 2014-12-11 ME MEP-2017-238A patent/ME02896B/me unknown
- 2014-12-11 EA EA201690894A patent/EA028921B1/ru not_active IP Right Cessation
- 2014-12-11 MX MX2016007566A patent/MX2016007566A/es unknown
-
2015
- 2015-10-02 NO NO15775410A patent/NO3221486T3/no unknown
-
2017
- 2017-11-09 CY CY20171101176T patent/CY1119583T1/el unknown
- 2017-11-28 HR HRP20171850TT patent/HRP20171850T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE035698T2 (en) | 2018-05-28 |
| LT3083562T (lt) | 2018-01-10 |
| EP3083562A1 (en) | 2016-10-26 |
| RS56615B1 (sr) | 2018-02-28 |
| NO3221486T3 (da) | 2018-09-08 |
| EP3083562B1 (en) | 2017-09-27 |
| MX2016007566A (es) | 2016-10-03 |
| US20160272585A1 (en) | 2016-09-22 |
| US9776964B2 (en) | 2017-10-03 |
| CA2928593A1 (en) | 2015-06-25 |
| BR112016011016A8 (pt) | 2018-01-30 |
| SI3083562T1 (sl) | 2017-11-30 |
| EA028921B1 (ru) | 2018-01-31 |
| AU2014366361A1 (en) | 2016-05-19 |
| PL3083562T3 (pl) | 2018-02-28 |
| AU2014366361B2 (en) | 2017-04-20 |
| KR20160084467A (ko) | 2016-07-13 |
| KR101807981B1 (ko) | 2017-12-11 |
| EA201690894A1 (ru) | 2016-10-31 |
| CN105793242B (zh) | 2018-02-16 |
| JP2016540007A (ja) | 2016-12-22 |
| PT3083562T (pt) | 2017-12-13 |
| ES2651858T3 (es) | 2018-01-30 |
| ME02896B (me) | 2018-04-20 |
| CY1119583T1 (el) | 2018-03-07 |
| CN105793242A (zh) | 2016-07-20 |
| JP6212644B2 (ja) | 2017-10-11 |
| WO2015094902A1 (en) | 2015-06-25 |
| HRP20171850T1 (hr) | 2018-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3083562T3 (da) | Cykliske phenoxyethylaminderivater og deres aktivitet som EP4-receptormodulatorer | |
| DK3363438T3 (da) | Substituerede 2-azabicykler og deres anvendelse som orexinreceptormodulatorer | |
| DK3848027T3 (da) | Octahydro-kondenserede azadecalinglucocorticoidreceptormodulatorer | |
| DK2875005T3 (da) | N-(3-heteroarylaryl)-4-arylarylcarboxamider og analoger som hedgehog pathway inhibitorer, og anvendelse deraf | |
| DK2989092T3 (da) | Quinazolinonderivater, der er anvendelige som fgfr-kinasemodulatorer | |
| DK2831079T3 (da) | BICYKLISKE HETEROCYKLISKE DERIVATER SOM MNK1- og MNK2-MODULATORER OG ANVENDELSER DERAF | |
| ES2635318T7 (es) | Moduladores P2X7 | |
| BR302012004796S1 (pt) | Configuração aplicada em suporte | |
| DK2900645T3 (da) | Herbicidt aktive 3-phenylisoxazolinderivater | |
| BR302012005698S1 (pt) | Configuração aplicada em garrafa | |
| DK3377483T3 (da) | N-substituerede indolderivater som pge2-receptormodulatorer | |
| DK2999699T3 (da) | Purindioner som wnt-vej-modulatorer | |
| DK2970442T3 (da) | Gla-domæner som terapeutiske midler | |
| DK3319963T3 (da) | Substituerede 4-azaindoler og deres anvendelse som glun2b receptormodulatorer | |
| DK2917181T3 (da) | Heteroarylderivater og anvendelser deraf | |
| DK2861573T3 (da) | Oxathiazin-derivater som antibakterielle og anticancer-stoffer | |
| BR302012005004S1 (pt) | Configuração aplicada em garrafa | |
| BR302012004223S1 (pt) | Configuracao aplicada em relogio | |
| DK3288940T5 (da) | Azabenzimidazoler og deres anvendelse som ampa-receptormodulatorer | |
| DK2809669T3 (da) | Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika | |
| CO6910195A2 (es) | Moduladores selectivos del receptor andrógeno | |
| DK2875016T3 (da) | Carbamat-/urinstofderivater | |
| BR302012003887S1 (pt) | Configuração aplicada em suporte | |
| DK3145916T3 (da) | Imidazolderivater som formylpeptidreceptormodulatorer | |
| DK3057963T3 (da) | Piperazinderivater og anvendelse deraf som lægemidler |